Oxford Outcomes Ltd, Seacourt Tower, West Way, Oxford, OX2 0JJ, UK.
Expert Rev Pharmacoecon Outcomes Res. 2010 Jun;10(3):269-81. doi: 10.1586/erp.10.30.
In the patient-reported outcomes (PROs) field, strict regulatory requirements must be met for qualitative research that contributes to labeling claims for medicinal products. These requirements not only emphasize the importance of reaching saturation but also of providing documentary evidence that saturation has been reached. This paper reviews qualitative literature for useful definitions of the concept and for practical approaches for assessing saturation. The paper considers approaches in light of the rigorous regulatory requirements for PRO research that are used to support labeling claims for medicinal products and the wider requirements for flexibility and creativity in qualitative research in general. This assessment is facilitated by the use of examples from our past qualitative PRO studies. Based on conclusions from this assessment, we offer preliminary recommendations for future qualitative PRO studies for assessing and documenting saturation.
在患者报告结局(PROs)领域,为了支持药品标签声称,定性研究必须满足严格的监管要求。这些要求不仅强调了达到饱和的重要性,还强调了提供达到饱和的文件证据的重要性。本文综述了定性文献中关于该概念的有用定义以及评估饱和的实用方法。本文考虑了这些方法在用于支持药品标签声称的 PRO 研究的严格监管要求以及定性研究在一般情况下的灵活性和创造性的更广泛要求方面的适用性。本文通过使用我们过去的定性 PRO 研究的例子来促进这一评估。基于这一评估的结论,我们为未来的定性 PRO 研究提供了初步建议,以评估和记录饱和情况。